Selection of thrombolytic therapy beyond 3 h using magnetic resonance imaging.
about
Treating the acute stroke patient as an emergency: current practices and future opportunities.Neuroprotection and thrombolysis: combination therapy in acute ischaemic strokeDiffusion tensor imaging and magnetic resonance spectroscopy in traumatic brain injury: a review of recent literature.Early experience of translating pH-weighted MRI to image human subjects at 3 Tesla.Imaging and treatment of patients with acute stroke: an evidence-based review.Computed tomography and magnetic resonance perfusion imaging in ischemic stroke: definitions and thresholds.Pretreatment diffusion- and perfusion-MR lesion volumes have a crucial influence on clinical response to stroke thrombolysisDefining the ischemic penumbra using hyperacute neuroimaging: deriving quantitative ischemic thresholdsMagnetic resonance diffusion-perfusion mismatch in acute ischemic stroke: An updateExperimental models, neurovascular mechanisms and translational issues in stroke research.Biochemical and bioimaging markers for risk assessment and diagnosis in major cardiovascular diseases: a road to integration of complementary diagnostic tools.Endovascular reperfusion therapy in acute ischaemic stroke.Applicability of biomarkers in ischemic stroke.Successful outcome after endovascular thrombolysis for acute ischemic stroke with basis on perfusion-diffusion mismatch after 24 h of symptoms onset.Past, present and future of alteplase for acute ischemic stroke.Determinants of the distribution and severity of hypoperfusion in patients with ischemic strokePerfusion CT: is it clinically useful?What's hot in neuroimaging acute stroke?MR mismatch profiles in patients with intracranial atherosclerotic stroke: a comprehensive approach comparing stroke subtypes.Rapid advanced neuroimaging assessment in acute stroke.Use of susceptibility-weighted imaging in assessing ischemic penumbra: A case report.Evaluation of the clinical-diffusion and perfusion-diffusion mismatch models in DEFUSE.The MRA-DWI mismatch identifies patients with stroke who are likely to benefit from reperfusion.Identifying implications of thrombolysis for stroke rehabilitation: knowledge gaps in current research.Benign oligemia despite a malignant MRI profile in acute ischemic stroke.Magnetic resonance characterization of ischemic tissue metabolism.Predicting stroke evolution: comparison of susceptibility-weighted MR imaging with MR perfusion.European Cooperative Acute Stroke Study-4: Extending the time for thrombolysis in emergency neurological deficits ECASS-4: ExTEND.Clinical value of computed tomography perfusion source images in acute stroke.Search for a map and threshold in perfusion MRI to accurately predict tissue fate: a protocol for assessing lesion growth in patients with persistent vessel occlusion.Future advances in the treatment of acute ischemic stroke
P2860
Q28196628-76000319-049F-49AE-A93D-49D765E22268Q28199814-C526B2F9-4BF3-4CE8-BD10-1E1BBFD5A04DQ30739121-5C5CEE20-D163-410B-9D9C-9386F35AFD38Q33704792-7001E151-0988-487A-AF91-2C311BBA45E2Q33926874-94076DB6-D183-408D-8AD6-35D71C3641D9Q33973699-D91B39AE-8A82-4BBC-A449-B93DBD1AABE0Q34171137-F7ADE51E-F389-4327-9E71-9A6C227532FAQ35624277-64415D3D-ACC6-47F3-82A0-BB08FDA3FAECQ35859444-C33F0D07-C1FB-46A6-9583-5B16C3716ED4Q36497042-FB7F8298-3362-4452-A1E2-9AE7FC2EBAF7Q36738090-E65C6A4B-F291-43D4-89CD-F93CFB3D567DQ36785937-BB594634-C458-4596-99D9-85BC02707EBFQ36986354-B781A573-DB11-4455-ACEB-CABD1518C6A4Q36991622-257E0308-3C0B-4BC1-A295-1CC2078FFB74Q37083630-DF134A04-A53E-4981-B7B3-5630D790AEECQ37179041-C85B2AD5-5F9A-4AA1-84B0-7C0CC08BC96FQ37244433-AB49EE6B-6173-4AF5-8DBC-ADCF9C0E1F1BQ37244526-DDBC1276-730C-416D-BDF9-5B707821EF3CQ37317803-AD3FFDBA-AF73-40DB-BC2A-A71EA97E92A5Q37453631-4AEBF4E6-B0EA-4815-9FD5-FC9D31179451Q37646738-2C4B9C7F-B1C5-43B1-AA7F-6960DE607823Q37701376-E30DBDF3-213A-4F52-B4DD-F5296BDF6947Q37701492-B704D115-EACD-4707-8879-0C60C7DAB23AQ38051668-172411C4-0502-43B9-A6A1-26C91C6A1ACAQ39945042-096FC42D-8093-42A7-AB75-02FEC8543F49Q39979430-4CC8F87D-E959-4694-8CAE-B64BDA612AA6Q46082175-D0521D0F-D9F7-41EB-81BE-9A864FC429E7Q48066036-69E642EB-3DA9-4C9C-B393-EDA6EE2EE874Q48411739-546F200F-00E3-4D70-840E-3B16EDE2159FQ48944917-A45D4FF4-C49C-4CFF-9CE6-9396E4F69CC0Q58619261-C482626E-9854-4E2E-923A-39078FB3FF19
P2860
Selection of thrombolytic therapy beyond 3 h using magnetic resonance imaging.
description
2005 nî lūn-bûn
@nan
2005 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Selection of thrombolytic therapy beyond 3 h using magnetic resonance imaging.
@ast
Selection of thrombolytic therapy beyond 3 h using magnetic resonance imaging.
@en
type
label
Selection of thrombolytic therapy beyond 3 h using magnetic resonance imaging.
@ast
Selection of thrombolytic therapy beyond 3 h using magnetic resonance imaging.
@en
prefLabel
Selection of thrombolytic therapy beyond 3 h using magnetic resonance imaging.
@ast
Selection of thrombolytic therapy beyond 3 h using magnetic resonance imaging.
@en
P2093
P1476
Selection of thrombolytic therapy beyond 3 h using magnetic resonance imaging.
@en
P2093
Kenneth S Butcher
Mark Parsons
Stephen M Davis
P356
10.1097/00019052-200502000-00010
P577
2005-02-01T00:00:00Z